Rutgers Health/Robert Wood Johnson Medical School
Pediatric Hematology-Oncology fellowship · New Brunswick, NJ · Program website
Pediatrics residency here · Other fellowships: Neonatal-Perinatal Medicine · Pediatric Endocrinology
Roster not collected yet. There's no list of this program's own faculty, trainees, or papers yet. Below is Rutgers Health's research in pediatric hematology-oncology, which the program shares with other departments and affiliated hospitals.
Pediatric Hematology-Oncology at Rutgers Healthshared by every program there, not this program's own
Institution-level: all pediatric hematology-oncology publications from Rutgers Health and affiliated institutions, since 2022. Updated 2026-11-07; refreshed daily.
Works per year · * 2026 so far
Pediatric Hematology-Oncology research topics at Rutgers Health
Papers in the window; each links to the list on OpenAlex.
- Cancer Immunotherapy and Biomarkers 109
- Pancreatic and Hepatic Oncology Research 89
- Cancer survivorship and care 76
- CAR-T cell therapy research 74
- Colorectal Cancer Treatments and Studies 49
- Global Cancer Incidence and Screening 47
- Cutaneous Melanoma Detection and Management 42
- Multiple Myeloma Research and Treatments 40
Most cited at Rutgers Health since 2024
All pediatric hematology-oncology papers there on OpenAlex
- Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Kayleigh Pavitra Bhangdia et al. · The Lancet Oncology · 2026 · PubMed · cited 182
- Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trialAlexander Babatunde Olawaiye et al. · The Lancet · 2025 · PubMed · cited 74
- CAR T Cells and T-Cell Therapies for CancerJennifer N. Brudno et al. · JAMA · 2024 · PubMed · cited 403
- Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancerCaitlin A. McIntyre et al. · Cancer Cell · 2024 · PubMed · cited 85
- Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 studyMohamad Ezzeddine Allaf et al. · The Lancet Oncology · 2024 · PubMed · cited 104
- Linvoseltamab for Treatment of Relapsed/Refractory Multiple MyelomaNaresh Bumma et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 205
- Acute lymphoblastic leukaemiaLuca Pagliaro et al. · Nature Reviews Disease Primers · 2024 · PubMed · cited 202
- Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL TrialHuabin Hu et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 93
- Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancerRay Pillai et al. · Science Advances · 2024 · PubMed · cited 81
- Embracing cancer complexity: Hallmarks of systemic diseaseCharles Swanton et al. · Cell · 2024 · PubMed · cited 570
Add to your program's websitea badge, your paper list, a feed
For program directors and coordinators. Both update with the site and need no account.
<a href="https://openprograms.org/programs/rutgers-health-robert-wood-johnson-medical-schoo-peds-heme-onc"><img src="https://openprograms.org/programs/rutgers-health-robert-wood-johnson-medical-schoo-peds-heme-onc/badge.svg" alt="Rutgers Health/Robert Wood Johnson Medical School Pediatric Hematology-Oncology fellowship on OpenPrograms" height="20"></a>Something wrong or missing on this page? Use the correction form below; changes show up in both.